Hospital Preventive Medicine,1 Institute of Microbiology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland2
Received 4 February 2003/ Returned for modification 16 March 2003/ Accepted 24 April 2003
A novel medium, Oxacillin Resistant Screening Agar (ORSA) medium,
was evaluated for the screening of specimens for methicillin-resistant
Staphylococcus aureus (MRSA) in the hospital setting. Screening
swabs (swabs of the nose, throat, perineum, and infected sites)
were inoculated onto the new ORSA medium and into an enrichment
broth (Muller-Hinton broth supplemented with NaCl and oxacillin).
After 24 h of incubation, the enrichment broth was subcultured
onto one ORSA plate and one lipovitellin Chapman salt agar plate.
The sensitivities for the detection of MRSA were calculated
for each medium alone and for the media in combination. A low
sensitivity (74%) was obtained when ORSA medium was used alone
as a primary culture, whereas the sensitivity was 88% when a
single selective enrichment broth was used. Among the 414 blue
colonies observed on ORSA plates, only 47% were found to be
MRSA, 40% were coagulase-negative staphylococci, 7% were
Enterococcus species, and 2% were methicillin-sensitive
S. aureus. The optimal
incubation time for the ORSA plates was evaluated. On primary
culture, 38% of the blue MRSA colonies were visible only after
48 h of incubation (no blue colonies were not seen after 24
h of incubation), whereas 94% of the colonies were already visible
at 24 h when ORSA plates were used for subcultures. In conclusion,
the advantage of the novel ORSA medium is the ease of recognition
of mannitol-fermenting bacteria, but further identification
tests are needed to confirm the identification of
S. aureus.
An enrichment broth is still needed to ensure a good sensitivity
for the recovery of MRSA, and an incubation time of 48 h is
required for primary culture on ORSA medium.
The incidence of nosocomial infections caused by methicillin-resistant
Staphylococcus aureus (MRSA) continues to increase worldwide.
Rapid assessment of clinical specimens for the presence of MRSA
is an important part of the infection control measures taken
to control the spread of MRSA and, thus, to decrease hospitalization
costs. In hospitals with low rates of MRSA, it is probably important
to detect each patient colonized or infected with MRSA. Thus,
the negative predictive value of the screening test should be
high. Although PCR-based methods have recently been developed
for the direct detection of MRSA in specimens (
2,
3), these
methods remain expensive and cannot be done in every laboratory.
Evaluation of their results, as well as their costs and benefits
in terms of patient management and infection control procedures,
should be undertaken. Thus, new screening media for the improved
detection of MRSA have recently been developed (
6-
8). In this
study, we evaluated the usefulness of one of these novel media,
the Oxacillin Resistant Screening Agar (ORSA) medium (Oxoid
Limited, Basingstoke, England), for the screening of specimens
for MRSA in a hospital setting. This medium uses aniline blue
to detect mannitol fermentation in staphylococci. The antibiotic
supplement (100,000 IU of polymyxin B and 2.0 mg of oxacillin
per liter) and sodium chloride concentration (5.5%) have the
potential to reduce the growth of nonstaphylococcal bacteria
and select for MRSA. The study was designed to evaluate (i)
the sensitivity of the procedure for the recovery of MRSA from
patient specimens by using ORSA base medium alone as a primary
culture medium or as an enrichment broth medium for subculture,
(ii) the proportion of samples that do not contain MRSA but
that show the growth of blue colonies on ORSA medium, and (iii)
the optimal incubation time.
Setting. The University Hospital of Lausanne is an 870-bed tertiary-care
hospital. The proportion of MRSA isolates among all
S. aureus isolates in the hospital was previously found to be <5% (
1)
and can thus be considered low. Screening samples were obtained
from the following individuals: (i) rehospitalized patients
known to have been positive for MRSA during a previous hospitalization,
(ii) patients transferred from a foreign hospital, (iii) the
roommates of a patient known to be infected or colonized with
MRSA, (iv) staff members and/or patients from a ward with a
suspected cluster of cases of MRSA infection, and (v) patients
screened after treatment for MRSA eradication. The screening
samples obtained from each patient included swabs (sterile transport
swab; Copan, Brescia, Italy) of the nose, the throat, the perineum,
and all infected sites. The nose, throat and perineal swabs
from all patients with a negative or unknown history of MRSA
infection or colonization were pooled for each analysis.
Bacteriology. Each specimen was inoculated onto two primary culture media: an ORSA base medium plate composed of (per liter) peptone (11.8 g), yeast extract (9.0 g), mannitol (10.0 g), NaCl (55.0 g), lithium chloride (5.0 g), aniline blue (0.2 g), and agar (12.5 g) selectively supplemented with 100,000 IU of polymyxin B and 2.0 mg of oxacillin (Oxoid Limited) and Mueller-Hinton broth composed of (per liter) beef extract (3.0 g), acid hydrolysate of casein (17.5 g), and starch (1.5 g; BBL Becton Dickinson, Heidelberg, Germany) supplemented with 6 mg of oxacillin per liter and 45 g of NaCl per liter (OX-MH broth). After 24 h of incubation, the OX-MH broth was subcultured onto one ORSA plate and one lipovitellin salt agar (lipovitellin salt-mannitol ) plate composed of (per liter) pancreatic digest of casein (5.0 g), peptic digest of animal tissue (5.0 g), beef extract (1.0 g), NaCl (75.0 g), D-mannitol (10.0 g), phenol red (25 mg), and agar (15.0 g; BBL Becton Dickinson) supplemented with 20 g of egg yolk per liter (5). All agar plates were incubated aerobically for 48 h at 35°C and were read every day.
Each morphotype of mannitol-fermenting colonies was subcultured onto a blood agar plate and identified by conventional biochemical tests, including Gram staining and catalase, DNase, and latex agglutination (Pastorex Staph Plus; Bio-Rad, Redmond, Wash.) tests. Resistance to methicillin was determined by the disk diffusion method and the oxacillin agar screen test according to the guidelines of the National Committee for Clinical Laboratory Standards (4). The MRSA-Screen (Denka-Seiken, Tokyo, Japan) was also used on several occasions to confirm the resistance. Species identification of isolates other than S. aureus was performed with the Vitek 2 automated system (bioMérieux, Marcy l'Etoile, France) and the ID32 Strep test (bioMérieux).
In order to optimize the procedure for the detection of MRSA,
the sensitivity of each medium alone or in combination was analyzed.
From February 2001 to January 2002, 7,929 specimens or pools
of specimens were analyzed. These specimens were obtained from
2,157 patients or staff members. Among these specimens, 1,112
(14%) were positive for MRSA. This served as the reference value
to define a sensitivity of 100%. The sensitivity for the detection
of MRSA was then calculated for each medium alone or the two
media in combination (Table
1). A low sensitivity (74%) was
obtained when ORSA medium alone was used as a primary culture.
The sensitivity increased with the number of media included
in the procedure.
fig.ommitted |
TABLE 1. Sensitivities for detection of MRSA in each medium alone or in combination
| |
In order to evaluate the proportion of blue colonies growing
on ORSA plates that were not MRSA, we analyzed all specimens
or pools of specimens (
n = 1,427) recovered from April to August
2001 for which complete data were available after 24 and 48
h of incubation. They were obtained from 540 patients or staff
members. Blue colonies grew from 399 of these specimens. Among
the 414 blue colonies (some specimens showed the presence of
different morphotypes), 47% were found to be MRSA, 40% were
coagulase-negative staphylococci, 2% were methicillin-sensitive
S.
aureus, and 7% were
Enterococcus species (
Enterococcus faecalis or
Enterococcus gallinarum) (Table
2; Fig.
1). Among the 166
coagulase-negative staphylococci, a subset of 76 isolates was
further identified to the species level. Thirty-seven (48.7%)
were
Staphylococcus haemolyticus, 11 (14.4%) were
Staphylococcus warneri, 3 (3.9%) were
Staphylococcus epidermidis, 2 (2.6%)
were
Staphylococcus cohnii, 1 (1.3%) was
Staphylococcus hominis,
and 22 (28.9%) were
Staphylococcus species not identified to
the species level with the Vitek 2 automated system.
fig.ommitted |
TABLE 2. Distributions of blue colonies on ORSA plates at 48 h of incubation (primary cultures and subcultures) by species and sampling site (one morphotype per analysis)
| |
fig.ommitted |
FIG. 1. Distributions of the principal species or genera of the 414 blue colonies from 1,427 specimens observed on ORSA medium. MSSA, methicillin-sensitive S. aureus; Coag. neg., coagulase negative.
| |
Twenty-two (52%) of the nonpooled nose, throat, and perineal
swab specimens from which blue colonies that were not
S. aureus (
n = 42) grew were perineal swabs. In addition, 78 primary ORSA
medium cultures of pooled specimens could be retrospectively
analyzed since photographs were taken at 24 and 48 h of incubation.
According to the positions of the blue colonies on the plate,
68 of them (79%) could be attributed to perineal swabs. Among
the blue colonies that grew from the pooled nose, throat, and
perineal swab specimens, 152 of 169 (89.9%) were not
S. aureus,
whereas among the blue colonies that grew from nonpooled swab
specimens of the same sites, only 42 of 181 (23.2%) were not
S. aureus. This difference might be explained by the fact that
nonpooled specimens were mainly obtained from patients colonized
or infected with MRSA after treatment for MRSA eradication.
The optimal incubation time for the ORSA plates was evaluated with the data for the 196 MRSA colonies recovered during the period from April to August 2001. Among the 144 MRSA colonies that were detected on primary culture, 55 (38%) were visible only after 48 h of incubation (no blue colonies were observed after 24 h of incubation). However, among the 79 MRSA colonies detected on the ORSA plate used for subculture, 94% were detected after only 24 h of incubation.
The use of a laboratory procedure that is sensitive for the
detection of MRSA from patient specimens is crucial if one wants
to limit the spread of this multiresistant microorganism. The
use of an enrichment and selective broth has always been proposed
for that purpose. The drawback of this method, which has a high
sensitivity, is a prolonged delay between the time of specimen
collection and the time that results are available (in general,
a minimum of 3 days). Thus, methods should be optimized in order
to reduce the laboratory workload and decrease this delay between
the time of collection and the time that results are available
without a loss of the sensitivity of the method. Our results
show that one cannot avoid the use of an enrichment broth without
a substantial loss of sensitivity. However, use of the ORSA
plates as primary culture allowed the earlier detection of MRSA
on several occasions (data not shown). Thus, ORSA plates and
enrichment broth should be used for primary culture.
The advantage of the ORSA medium is the easy detection of mannitol-fermenting colonies (the appearance of a blue color). However, in our study, about half of the blue colonies were not MRSA. This proportion is higher than that reported in another study (26%) (7). This might be because in the latter study, fewer specimens from colonized sites (nares and perineum) were investigated. Indeed, our results show that most of these non-S. aureus mannitol-fermenting bacteria were isolated from perineal swabs.
As reported in the previous study (7) and confirmed in the present study, an incubation time of 24 h for a primary culture with ORSA plates was not sufficient for the detection of MRSA and the incubation time should be extended to 48 h. However, an incubation time of 24 h for a subculture in an enrichment broth is sufficient, probably because the bacteria are already in the growth phase in the broth.
These results have allowed us to optimize our protocol for the detection of MRSA in screening specimens (Fig. 2). The major advantage of this protocol is the reduced amount of time for the procedure (2 days instead of 3 days) because the ORSA subculture is incubated for only 24 h. The ORSA medium also has the advantage of easy interpretation, especially for specimens other than perineal swabs. The latter are now treated separately from the pool, as most of the non-MRSA blue colonies were observed in these specimens. Even though LSM did not significantly increase the sensitivity of the method, this medium was kept for the subculture of all specimens and for primary culture of perineal specimens. Indeed, the growth of mannitol-fermenting and lipase-positive colonies on the LSM plate together with the growth of blue colonies on the ORSA plates is highly suggestive of the presence of MRSA and thus offers the technician help with the identification of blue colonies on the ORSA plates. However, to reduce the workload in the laboratory, further tests for the identification of MRSA are performed only with suspected colonies growing on ORSA medium. The addition of the LSM plate was useful because it had not been possible to make a presumptive identification of S. aureus on ORSA plates on the basis of the morphologies of the blue colonies.
fig.ommitted |
FIG. 2. Laboratory procedure for the screening of MRSA with ORSA medium. ORSAB, ORSA base medium. (Darker and lighter streaks on the plates represent blue and yellow colonies on ORSA and LSM plates, respectively.)
| |
In conclusion, the main advantage of the novel ORSA medium is
the ease of recognition of mannitol-fermenting bacteria. However,
further identification tests are needed to confirm the identification
of
S. aureus since half of the blue colonies were not
S. aureus.
Moreover, an enrichment broth is still needed to ensure a good
sensitivity of the method for the recovery of MRSA, and an incubation
time of 48 h is required for the primary culture. Thus, the
procedure still requires a minimum of 2 days before final results
can be obtained.
We thank Fabien Peter and Dorothée Raffalli for excellent
technical assistance and Patrick Francioli and Paul Majcherczyk
for reviewing the manuscript.
- Blanc, D. S., D. Pittet, C. Ruef, A. Widmer, K. Muhlemann, C. Petignat, S. Harbarth, R. Auckenthaler, J. Bille, R. Frei, R. Zbinden, R. Peduzzi, V. Gaia, H. Khamis, E. Bernasconi, and P. Francioli. 2002. Epidemiology of methicillin-resistant Staphylococcus aureus: results of a nationwide survey in Switzerland. Swiss Med. Wkly. 132:223-229.
- Francois, P., D. Pittet, M. Bento, B. Pepey, P. Vaudaux, D. Lew, and J. Schrenzel. 2003. Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay. J. Clin. Microbiol. 41:254-260.
- Huletsky, A., F. Gagnon, V. Ross Bach, K. Truchon, F. J. Picard, and M. G. Bergeron. 2002. Less than one-hour detection of methicillin-resistant Staphylococcus aureus directly from nasal swabs by real-time PCR using the smart cycler. Clin. Microbiol. Infect. 8(Suppl. 1):85.
- Jorgensen, J. H., R. Cleeland, W. Craig, G. Doern, M. J. Ferraro, S. M. Finegold, S. L. Hansen, R. N. Jones, M. A. Pfaller, D. A. Preston, L. B. Reller, J. M. Swenson, and J. A. Waitz. 1991. Performance standards for antimicrobial disk susceptibility testing. Approved standard M2-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
- Merlino, J., R. Gill, and G. J. Robertson. 1996. Application of lipovitellin-salt-mannitol agar for screening, isolation, and presumptive identification of Staphylococcus aureus in a teaching hospital. J. Clin. Microbiol. 34:3012-3015.
- Merlino, J., M. Leroi, R. Bradbury, D. Veal, and C. Harbour. 2000. New chromogenic identification and detection of Staphylococcus aureus and methicillin-resistant S. aureus. J. Clin. Microbiol. 38:2378-2380.
- Simor, A. E., J. Goodfellow, L. Louie, and M. Louie. 2001. Evaluation of new medium, Oxacillin Resistance Screening Agar base, for the detection of methicillin-resistant Staphylococcus aureus from clinical specimens. J. Clin. Microbiol. 39:3422.
- Wertheim, H., H. A. Verbrugh, C. van Pelt, P. de Man, A. van Belkum, and M. C. Vos. 2001. Improved detection of methicillin-resistant Staphylococcus aureus using phenyl mannitol broth containing aztreonam and ceftizoxime. J. Clin. Microbiol. 39:2660-2662.
作者:
D. S. Blanc A. Wenger and J. Bille 2007-5-10